CVE-2020-16247

Executive Summary

CVE-2020-16247 is a medium-severity vulnerability (CVSS 6.8) affecting the Philips Clinical Collaboration Platform, versions 12.2.1 and prior. The flaw is classified as an "Exposure of a Resource to the Wrong Control Sphere" (CWE-668), meaning the application exposes a sensitive resource to actors who should not have access. Successful exploitation could allow an unintended actor to access protected resources, potentially leading to unauthorized disclosure of clinical data or manipulation of collaboration features. The patch is claimed in version 12.2.5, released in May 2020, though this is only confirmed by a single source (the CNA) and has not been independently verified.

Technical Analysis

The NVD description for CVE-2020-16247 states that the Philips Clinical Collaboration Platform, versions 12.2.1 and prior, "exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource." This is a generic description of the CWE-668 weakness class, which occurs when software does not properly segregate and protect privileged resources, allowing them to be accessed through a broader control sphere than intended.

Vulnerability Mechanism: At a fundamental level, the application environment does not properly enforce authorization boundaries. The resource in question—though its exact nature is not disclosed in the NVD or CNA data—is accessible to a control sphere that includes unintended actors. This could manifest as an accessible service, an exposed API endpoint, a device admin panel reachable from an untrusted network, or a debug interface left enabled in production. Given the classification and the typical architecture of clinical collaboration platforms (which may include imaging servers, communication gateways, and web-based consoles), the resource is likely network-accessible and reachable over an enterprise or extended network segment.

Attack Surface: The attack surface is the network-facing interface(s) of the Philips Clinical Collaboration Platform. The platform is designed to facilitate communication and data sharing among clinical staff; therefore, it may expose web consoles, REST APIs, or inter-service communication ports. The vulnerability's control-sphere flaw suggests that a resource intended for local or authenticated use is reachable without proper access restrictions. The CVSS vector (AV:N/AC:L/Au:N/C:P/I:P/A:P) indicates a network-accessible flaw with low attack complexity, requiring no authentication, and having partial impact on confidentiality, integrity, and availability.

Code-Level Explanation: Insufficient technical detail is available in the source data to identify specific function names, API paths, or parameters. The description is deliberately vague, likely to avoid providing a roadmap for exploitation while a patch is being disseminated. Without vendor advisory specifics, the precise mechanism remains opaque; however, the vulnerability class strongly suggests improper access-control lists, missing firewall rules, or misconfigured session management on a particular service.

Exploitation Scenarios

No public PoC or exploit code is available for CVE-2020-16247. The attack chain below is inferred strictly from the vulnerability class (CWE-668) and the CVSS vector. All steps are described at the class level; do not treat any step as a verified technical fact.

1. Reconnaissance / Target Identification: An attacker (likely an opportunistic scanner or a threat actor targeting healthcare infrastructure) identifies a Philips Clinical Collaboration Platform instance by fingerprinting the network service banner, HTTP response headers, or login pages. Shodan or similar internet-wide scanning can also identify exposed instances. Affected versions are 12.2.1 and prior.

2. Triggering the Flaw: The attacker sends a direct network request to the resource that is improperly exposed. Because the flaw is an access-control deficiency, the attacker does not need valid credentials or a session token—the resource responds to requests from the wrong control sphere (i.e., the unauthenticated external network). The request could target a management endpoint, a configuration retrieval path, or a diagnostic interface; the exact target is unidentified in public data.

3. Payload / Execution Method: At the vulnerability-class level, the "payload" is simply a crafted HTTP/HTTPS request or a raw TCP session targeting the exposed resource. Since no authentication is required (Au:N) and attack complexity is low (AC:L), the request is straightforward—no complex obfuscation or deep packet manipulation is needed. The intent is to elicit a response from the resource, potentially retrieving sensitive data or triggering a state change. In a CWE-668 scenario, the server may respond with data or perform an action that should have been restricted to an internal control sphere.

4. Post-Exploitation Impact: If successful, the attacker gains read access to the resource's content, which may include clinical collaboration metadata, configuration files, user directory information, or access tokens. The partial integrity impact (I:P) suggests that the attacker may also be able to modify some data or system state through the exposed resource, possibly enabling session hijacking or service disruption. The partial availability impact (A:P) indicates potential denial-of-service conditions on the exposed resource.

Impact Assessment

The business impact is significant given the healthcare context. The Philips Clinical Collaboration Platform is used in hospital environments to streamline clinical workflows, imaging data sharing, and multidisciplinary team communications. Unauthorized access to this platform could expose protected health information (PHI) or clinical operation data, triggering regulatory obligations under HIPAA and GDPR. The CVSS base score of 6.8 (Medium severity) reflects a single-layered access control failure with moderate impact; however, in a healthcare environment, the real-world blast radius can be higher than the numeric score suggests, due to the sensitivity of the data and the criticality of clinical operations.

Affected systems: Philips Clinical Collaboration Platform, versions 12.2.1 and prior. The exact network architecture (e.g., whether the platform is typically deployed on an internal hospital LAN or exposed to the internet) is not specified in the provided data. Attackers inside the hospital network (e.g., via a compromised workstation or malicious insider) can exploit this locally; remote exploitation depends on whether the platform is reachable from untrusted networks.

Blast radius: A successful exploit can lead to unauthorized disclosure of clinical collaboration data, configuration data, or user credentials. In a worst-case scenario, the attacker could pivot to internal network segments because the platform may have trusted connections to imaging repositories, EHR systems, or directory services. Lateral movement from this platform would significantly escalate the impact.

Detection Guidance

The following detection rules are generic and can be adapted to the specific deployment environment. They detect anomalies consistent with the CWE-668 exposure (unauthenticated access attempts to sensitive management or collaboration resources).

Sigma Rule

title: Unauthenticated Access to Philips Clinical Collaboration Platform
id: 8e334a6a-7b3f-4b9a-8a4e-0c1e2f3a4b5c
status: experimental
description: Detects network requests targeting sensitive Philips Clinical Collaboration Platform resources without prior authentication, indicative of CVE-2020-16247 exploitation.
logsource:
  category: webserver
  product: apache
  # Adjust product to match your web server (e.g., iis, nginx)
detection:
  selection:
    c-uri|contains:
      - '/admin'
      - '/config'
      - '/api/internal'
      - '/debug'
      # Adjust these paths based on actual platform resource paths
    sc-status: 200
  filter_auth:
    c-uri|contains: '/login'
  condition: selection and not filter_auth
level: high
tags:
  - attack.t1190
  - cve.2020.16247

YARA Rule

rule Philips_Clinical_Platform_CVE_2020_16247
{
    meta:
        author = "ValtersIT Threat Intel"
        description = "Detects network payloads or log strings referencing Philips Clinical Collaboration Platform exposed resource requests"
        date = "2024-10-01"
        cve = "CVE-2020-16247"
        severity = "high"
    strings:
        $s1 = "Clinical Collaboration" ascii nocase
        $s2 = "Philips" ascii nocase
        $s3 = "12.2" ascii nocase
        $s4 = "/config" ascii nocase
        $s5 = "/admin" ascii nocase
        $s6 = "unauthorized" ascii nocase
    condition:
        uint16(0) == 0x0a0d or filesize < 100KB  // Network capture or log file
        and 2 of them
}

Suricata IDS Rule

alert http any any -> $EXTERNAL_NET any (msg:"ET EXPLOIT Philips Clinical Collaboration Platform Unauthenticated Access Attempt (CVE-2020-16247)"; flow:established,to_server; http.uri; content:"/config"; nocase; http.uri; content:"/admin"; nocase; classtype:attempted-admin; sid:202016247; rev:1; metadata:created_at 2024_10_01, updated_at 2024_10_01;)

Elastic Detection

any where process.name == "httpd" or network.direction == "ingress"
// Adjust event types (e.g., 'network' or 'file') to match telemetry
[network where not cidrMatch(source.ip, "10.0.0.0/8", "172.16.0.0/12", "192.168.0.0/16") and
 destination.port in (80, 443) and
 url.path in ("/admin", "/config", "/api/internal", "/debug")]

Splunk SPL Query

index=proxy OR index=web
| search uri="/admin" OR uri="/config" OR uri="/api/internal" OR uri="/debug"
| eval internal_src = if(match(src_ip, "^(10\.|192\.168\.|172\.(1[6-9]|2[0-9]|3[01])\.)"), "internal", "external")
| where internal_src == "external"
| stats count by src_ip, uri, dest_ip, _time

Wazuh OSSEC Rule

<group name="philips,access_control,">
  <rule id="100247" level="12">
    <decoded_as>web</decoded_as>
    <description>Philips Clinical Collaboration Platform - Unauthenticated Access Attempt to Restricted Resource (CVE-2020-16247)</description>
    <match>/admin|/config|/api/internal|/debug</match>
    <url>https://nvd.nist.gov/vuln/detail/CVE-2020-16247</url>
    <group>attack.t1190,</group>
    <mitre>
      <id>T1190</id>
    </mitre>
  </rule>
</group>

Mitigation & Patch Guidance

Patch Confidence: 2/4 — CLAIMED. Only the CNA (Philips) claims the patch; no independent confirmation from security researchers or third-party sources is available in the provided dataset.

Immediate Mitigations (before patching):

1. Apply strict network segmentation. Restrict access to the Clinical Collaboration Platform to trusted internal IP ranges and clinical workstation subnets. Block access from the internet and from guest/patient Wi-Fi networks.
2. Enable or verify firewall rules (host-based and network-based) to deny inbound traffic to management interfaces, admin consoles, and any non-essential ports. If the platform architecture is unknown, perform a network scan to enumerate exposed services and lock down unnecessary ports.
3. Monitor access logs for anomalous unauthenticated requests, especially those targeting administrative or configuration paths. Implement the detection rules above with a security information and event management (SIEM) system.

Patch/Upgrade Steps:

1. Upgrade to Philips Clinical Collaboration Platform version 12.2.5 (released May 2020) which is claimed to remediate CVE-2020-16247.
2. Contact Philips service support at 1-877-328-2808, option 4, or via the regional service support portal to obtain the latest version and installation guidance. Validate eligibility of your current installation for the upgrade.
3. After patching, verify the version number on all platform nodes and confirm the removal of the exposure by re-scanning the network surface.

Long-Term Hardening:

1. Establish a patch management policy for clinical infrastructure, prioritizing security-relevant updates within 30 days of release for medium-severity CVEs in critical assets.
2. Adopt a zero-trust network architecture for clinical collaboration tools—require authentication on every resource and enforce least-privilege access, even within the hospital network.
3. Investigate whether the platform's resource exposure can be further constrained by application-level controls (e.g., disabling debug endpoints, hiding management interfaces, requiring client certificates).

References

1. NVD Entry: https://nvd.nist.gov/vuln/detail/CVE-2020-16247
2. Philips Product Security Website: https://www.philips.com/productsecurity
3. Philips Customer Service Solutions (for patch availability): https://www.usa.philips.com/healthcare/solutions/customer-service-solutions
4. CWE-668 — Exposure of Resource to Wrong Control Sphere: https://cwe.mitre.org/data/definitions/668.html
5. MITRE ATT&CK — T1190 Exploit Public-Facing Application: https://attack.mitre.org/techniques/T1190/

Exploit-in-the-Wild Evidence: None recorded. CISA KEV (Known Exploited Vulnerabilities) catalog does not include CVE-2020-16247. No public PoC, Nuclei template, or exploit code has been identified. No specific threat actor campaigns referencing this CVE have been documented in the provided dataset.